During a median of 41.7 months (IQR, 21.5–59.1 months) of follow-up period, five patients (1.5%) developed active TB in a median of 20.8 months (IQR, 13.9–22.4 months) after initiation of anti-TNF treatment (428/100,000 person-years). Here, TNF is linked to tuberculosis.